Doloromics

Doloromics is a biotechnology startup founded in 2020 and headquartered in the United States. Their slogan "Doloromics is developing precision medicines to conquer chronic pain" reflects their focus on finding precision medicines to conquer chronic pain. The company recently secured a significant milestone with a $6.67M Seed Round investment from Mayfield in February 2022. Doloromics operates in the biotechnology and health care industries, positioning itself at the forefront of tackling one of the most pressing global health challenges. This recent investment signifies a vote of confidence in the company's mission and potential to make a substantial impact in the field of chronic pain treatment.